Erythropoietin treatment in anaemic patients at the Nephrology Unit of the Steve Biko Academic Hospital - a retrospective, cross-sectional study

Erythropoietin treatment in anaemic patients at the Nephrology Unit of the Steve Biko Academic Hospital - a retrospective, cross-sectional study

Anaemia in chronic kidney disease (CKD) mostly results from a decrease in the production of erythropoietin (EPO) by the failing kidney. CKD progression requires treatment with erythropoiesis-stimulating agents and iron supplementation to ensure sufficient erythrocyte production. Best clinical practi...

Full description

Bibliographic Details
Main Author: Kok, Elandre
Other Authors: Marais, Andrè
Language:en
Published: University of Pretoria 2020
Subjects:
Anaemia
Chronic kidney disease
Erythropoiesis stimulating agent
Haemoglobin
Iron
UCTD
Online Access:http://hdl.handle.net/2263/76007
Kok, E 2020, Erythropoietin treatment in anaemic patients at the Nephrology Unit of the Steve Biko Academic Hospital - a retrospective, cross-sectional study, MSc Dissertation, University of Pretoria, Pretoria, viewed yymmdd http://hdl.handle.net/2263/76007

Internet

http://hdl.handle.net/2263/76007
Kok, E 2020, Erythropoietin treatment in anaemic patients at the Nephrology Unit of the Steve Biko Academic Hospital - a retrospective, cross-sectional study, MSc Dissertation, University of Pretoria, Pretoria, viewed yymmdd http://hdl.handle.net/2263/76007

Similar Items